Veterinary Medicines

Pimotab 10 mg chewable tablets for dogs

Authorised
  • Pimobendan
Download as PDF

Product identification

Medicine name:
Pimotab 10 mg chewable tablets for dogs
Pimotab 10 mg Tuggtablett
Active substance:
  • Pimobendan
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Pimobendan
    10.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Chewable tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QC01CE90
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Sweden
Available in:
  • Sweden
Package description:
  • Cardboard box of 50 tablets, Aluminium.OPA-Aluminium-PVC blisters containing 10 tablets.
  • Cardboard box of 30 tablets, Aluminium.OPA-Aluminium-PVC blisters containing 10 tablets.
  • Cardboard box of 100 tablets, Aluminium.OPA-Aluminium-PVC blisters containing 10 tablets.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • CP-Pharma Handelsgesellschaft mbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • CP-Pharma Handelsgesellschaft mbH
Responsible authority:
  • Swedish Medical Products Agency
Authorisation number:
  • 58751
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0297/004
Concerned member states:
  • Austria
  • Belgium
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Poland
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Swedish (PDF)
Published on: 2/05/2022
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Swedish (PDF)
Published on: 25/04/2024
Download

Combined File of all Documents

English (PDF)
Published on: 15/03/2024
Download

Public Assessment Report Pimotab NL-V-0297-001_005.pdf

English (PDF)
Published on: 15/03/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."